Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrence

[MEDPAGE TODAY]( Oncology Update Tuesday, April 18, 2023 [Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrence]( [Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanoma]( [FDA OKs Cell Therapy to Lower Infection Risk After Stem Cell Transplant]( ['Potential' New Option for Operable NSCLC]( [Adjuvant Combo May Change Practice in High-Risk Liver Cancer]( ADVERTISEMENT [In what could be a 'big shift' for cancer treatment, mRNA vaccine shows promise against melanoma]( An mRNA vaccine from Moderna shows promise at preventing recurrences of melanoma skin cancer, which could mark a turnaround for cancer vaccines. [READ MORE]( [Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer]( An experimental mRNA vaccine developed by Moderna Inc combined with Merck & Co's blockbuster immunotherapy Keytruda cut the risk of death or recurrence of the most deadly skin cancer by 44% compared... [READ MORE]( [Why melanoma is so deadly for men, and why it doesn’t have to be]( Men are much more likely to get skin cancer — and to die from it — than women. Here's what makes men so vulnerable to melanoma, the deadliest form of skin cancer. [READ MORE]( [Targeted Axillary Dissection with 125I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort.]( BACKGROUND: Targeted axillary dissection (TAD), with marking of the metastatic lymph node before neoadjuvant chemotherapy (NACT), is increasingly used for breast cancer axillary staging. In the case... [READ MORE]( [Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical implications.]( Biomarker-driven cancer therapy has revolutionized precision oncology. With a better understanding of tumor biology, tissue-agnostic targets have been characterized and explored which ultimately led... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-04-18&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011